| Period Ending | 30-Dec-2012 | 01-Jan-2012 | 02-Jan-2011 |
|---|
|
Total Revenue
|
125,948
|
136,591
|
191,677
| | Cost of Revenue | 64,750 | 65,944 | 126,692 | | |
Gross Profit
|
61,198
|
70,647
|
64,985
| |
|
Operating Expenses |
|
Research Development | 57,543 | 55,796 | 60,769 |
|
Selling General and Administrative | 19,056 | 22,287 | 27,239 |
|
Non Recurring | 1,062 | (109) | 27,172 |
|
Others |
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
| | | |
Operating Income or Loss
|
(16,463)
|
(7,327)
|
(50,195)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (108) | 912 | 51 |
|
Earnings Before Interest And Taxes | (16,571) | (6,415) | (50,144) |
|
Interest Expense |
-
|
-
|
-
|
|
Income Before Tax | (16,571) | (6,415) | (50,144) |
|
Income Tax Expense | 1,014 | 1,082 | (381) |
|
Minority Interest |
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (17,585) | (7,497) | (49,763) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
| | | |
Net Income
|
(17,585)
|
(7,497)
|
(49,763)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(17,585)
|
(7,497)
|
(49,763)
|
|